Seiji Kojima

Dec 2, 2024 | mdpi.com | Seiji Kojima

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 11, 2024 | cienciaysaludnatural.com | Miki Gibo |Seiji Kojima |Akinori Fujisawa |Takayuki Kikuchi

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan DOI: 10.7759/cureus.57860 – https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ El médico epidemiólogo Miki Gibo, afiliado a la Clínica Matsubara y al Hospital Yusuhara del Seguro Nacional de Salud en Yusuhara, Kochi, Japón, y sus colegas...

Apr 8, 2024 | cureus.com | Miki Gibo |Seiji Kojima |Akinori Fujisawa |Takayuki Kikuchi

SpecialtyPlease chooseI'm not a medical professional. Allergy and ImmunologyAnatomyAnesthesiologyCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI'm not a medical professional.